$238.92+4.64 (+1.98%)
Reinsurance Group of America, Incorporated provides life and health, and asset-intensive reinsurance in the United States, Latin America, Canada, Europe, the Middle East, Africa, Asia, and Australia.
Reinsurance Group of America, Incorporated in the Financial Services sector is trading at $238.92 with a market capitalization of $13.9B. Wall Street consensus targets $261.78 (9 analysts), implying a +9.6% move over the next 12 months. The stock is currently near its 52-week high of $245.00, remaining 16.9% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $6.48Bβ | $6.61Bβ | $6.23Bβ | $5.56Bβ | $5.29B |
| Gross Profit | β | β | β | β | β |
| Operating Income | $540.00Mβ | $608.00Mβ | $418.00Mβ | $431.00Mβ | $449.00M |
| Net Income | $330.00Mβ | $463.00Mβ | $253.00Mβ | $180.00Mβ | $286.00M |
Reinsurance Group of America, Incorporated provides life and health, and asset-intensive reinsurance in the United States, Latin America, Canada, Europe, the Middle East, Africa, Asia, and Australia. It offers individual and group life and health, di...
Growth boosts valuation multiples, but it doesnβt always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
Voya Financial's Retirement and Investment Management businesses, strategic acquisitions and capital returns support growth, though higher leverage and competition remain risks.
Solid retention, renewals, prudent pricing, exposure growth and improved digitization are expected to help CINF, RGA, OSCR, WTW and AFL outperform Q2 estimates.
Can higher net premiums help AMSF offset rising claims costs? Here's what could shape the insurer's Q2 results ahead of its July 21 earnings release.
MRSH heads into Q2 earnings with revenue and EPS growth expected, but rising operating expenses could make another earnings beat harder to achieve.